1. Home
  2. KD vs KRYS Comparison

KD vs KRYS Comparison

Compare KD & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kyndryl Holdings Inc.

KD

Kyndryl Holdings Inc.

HOLD

Current Price

$12.36

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$248.06

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KD
KRYS
Founded
2020
2015
Country
United States
United States
Employees
80000
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
7.8B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
KD
KRYS
Price
$12.36
$248.06
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$35.25
$297.60
AVG Volume (30 Days)
4.7M
254.5K
Earning Date
05-11-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
170.95
128.00
EPS
0.77
6.84
Revenue
$15,057,000,000.00
$389,130,000.00
Revenue This Year
$3.96
$40.88
Revenue Next Year
$0.41
$35.16
P/E Ratio
$16.31
$36.71
Revenue Growth
N/A
33.94
52 Week Low
$10.10
$123.03
52 Week High
$43.74
$298.30

Technical Indicators

Market Signals
Indicator
KD
KRYS
Relative Strength Index (RSI) 33.95 38.23
Support Level $11.34 $233.64
Resistance Level $13.81 $248.60
Average True Range (ATR) 0.51 9.14
MACD 0.45 -2.19
Stochastic Oscillator 42.98 9.64

Price Performance

Historical Comparison
KD
KRYS

About KD Kyndryl Holdings Inc.

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: